Patients with locally advanced cervical cancer benefit significantly from an innovative radiotherapy technique co-developed by MedUni Vienna under the direction of Richard Pötter and Christian Kirisits. The technique provides ...
Nov 27, 2020
0
3
For the first time, SAHMRI and University of Adelaide researchers are investigating gene therapy as an option to help people with metastatic bowel cancer.
Nov 26, 2020
0
59
Immunotherapy for cancer has made great advances and many patients can now receive effective treatments that were not available 10 years ago. However, there are certain types of cancer that do not respond to existing immunotherapy. ...
Nov 23, 2020
0
87
Prostate cancer is caused by elevated hormone levels, and tumors are generally treated using hormone therapy. However, after some time, tumor growth is no longer dependent on hormones, which results in resistance to treatment. ...
Nov 18, 2020
0
7
A preclinical study conducted at the Institute of Oncology Research (IOR, affiliated to USI Università dellaSvizzera italiana) reveals the role of aging cells in the formation of metastases and identifies a drug capable ...
Nov 13, 2020
0
122
The latest animation technology has revealed the molecular detail of how our bodies are protected from cancer by a key 'tumour suppressor' protein called p53.
Nov 11, 2020
0
15
University of Calgary scientists and members of the Clark H. Smith Brain Tumor Centre at the Arnie Charbonneau Cancer Institute at the Cumming School of Medicine (CSM) have discovered a way to stop the growth of glioblastoma, ...
Oct 27, 2020
0
4
A strategy for giving intermittent, high doses of the anti-cancer drug sunitinib is well-tolerated by patients with advanced cancer and increases concentrations of the drug in tumours, which is associated with improved survival, ...
Oct 24, 2020
0
3
An Edith Cowan University (ECU) study has revealed that a key blood marker of cancer could be used to select the most effective treatment for melanoma.
Oct 16, 2020
0
6
A research team at LKS Faculty of Medicine, The University of Hong Kong (HKUMed) reports that exosomes derived from Vδ2-T cells (Vδ2-T-Exos) can effectively control Epstein-Barr-virus-associated tumors and induce T-cell ...
Oct 12, 2020
0
57
